Status:
WITHDRAWN
Study of Sodium Bicarbonate in Restoring Blocked Catheters
Lead Sponsor:
University Health Network, Toronto
Conditions:
Cancer
Central Venous Catheterization
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a study looking at the use of sodium bicarbonate to restore the flow of blocked central line devices in patients with blood cancers. Central line devices uses thin tubes that are placed into ...
Eligibility Criteria
Inclusion
- Hematology patients with indwelling CVC/PICC line.
- Patients continuing to receive chemotherapy treatment for consolidation, intensification and maintenance regimens in hematological malignancies such as in acute leukemia, lymphoma, myelodysplastic syndrome, supportive care measures using blood products, ongoing anti-infective treatments, and nutrition.
- Patients whose CVC/PICC line becomes obstructed during routine care are being identified and presented to attending physician and pharmacist.
- Mechanical obstruction having been ruled out by visual inspection and manipulation of the patient's posture or extremities or both.
Exclusion
- Patients with hemodialysis line occlusions
- Anyone with documentation of prior history of alteplase allergy or hypersensitivity reactions
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 2 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03348826
Start Date
June 1 2020
End Date
September 2 2021
Last Update
September 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G 2M9